KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Net Cash Flow (2018 - 2025)

Vir Biotechnology's Net Cash Flow history spans 8 years, with the latest figure at $61.8 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 13.7% to $61.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$77.6 million, a 235.23% decrease, with the full-year FY2025 number at -$77.6 million, down 235.23% from a year prior.
  • Net Cash Flow hit $61.8 million in Q4 2025 for Vir Biotechnology, up from -$127.0 million in the prior quarter.
  • Over the last five years, Net Cash Flow for VIR hit a ceiling of $690.9 million in Q2 2022 and a floor of -$542.7 million in Q3 2022.
  • Historically, Net Cash Flow has averaged -$10.5 million across 5 years, with a median of -$40.6 million in 2021.
  • The widest YoY moves for Net Cash Flow: up 452.44% in 2022, down 1816.04% in 2022.
  • Tracing VIR's Net Cash Flow over 5 years: stood at -$364.2 million in 2021, then skyrocketed by 68.15% to -$116.0 million in 2022, then tumbled by 81.95% to -$211.1 million in 2023, then surged by 125.76% to $54.4 million in 2024, then grew by 13.7% to $61.8 million in 2025.
  • Business Quant data shows Net Cash Flow for VIR at $61.8 million in Q4 2025, -$127.0 million in Q3 2025, and -$61.7 million in Q2 2025.